RxNorm Semantic Concepts Index - 595

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "595".

RxCUINameTerm TypeTerm Type DescriptionIs Prescribable?
RxCUI: 595algestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). NO
RxCUI: 59500Peptidyl-D-amino acid hydrolaseSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59500Peptidyl-D-amino acid hydrolaseDesignated preferred name (PT) NO
RxCUI: 59500Peptidyl-D-amino acid hydrolaseFull form of descriptor (FN) NO
RxCUI: 59500Peptidyl-D-amino acid hydrolaseSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59501Hb 136(H19), Leu-proBritish preferred term (PTGB) NO
RxCUI: 59501Hb 136(H19), Leu-proSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59501Hb 136(H19), Leu-proDesignated preferred name (PT) NO
RxCUI: 59501Hb 136(H19), Leu-proFull form of descriptor (FN) NO
RxCUI: 59502L-Lysine oxidaseDesignated preferred name (PT) NO
RxCUI: 59502L-Lysine oxidaseFull form of descriptor (FN) NO
RxCUI: 595060ranibizumabFull form of descriptor (FN) YES
RxCUI: 595060ranibizumabIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). YES
RxCUI: 595060ranibizumabDesignated preferred name (PT) YES
RxCUI: 595060ranibizumabFull form of descriptor (FN) YES
RxCUI: 595060ranibizumabDesignated preferred name (PT) YES
RxCUI: 59513Blood group H alpha-2-fucosyltransferaseSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59513Blood group H alpha-2-fucosyltransferaseDesignated preferred name (PT) NO
RxCUI: 59513Blood group H alpha-2-fucosyltransferaseFull form of descriptor (FN) NO
RxCUI: 5953MonoiodotyrosineDesignated preferred name (PT) NO
RxCUI: 5953MonoiodotyrosineFull form of descriptor (FN) NO
RxCUI: 59537Hb 136(H14), Gly-asp, delta chainBritish preferred term (PTGB) NO
RxCUI: 59537Hb 136(H14), Gly-asp, delta chainSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59537Hb 136(H14), Gly-asp, delta chainDesignated preferred name (PT) NO
RxCUI: 59537Hb 136(H14), Gly-asp, delta chainFull form of descriptor (FN) NO
RxCUI: 59538Hb 121(GH4), Glu-val, beta chainBritish preferred term (PTGB) NO
RxCUI: 59538Hb 121(GH4), Glu-val, beta chainSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59538Hb 121(GH4), Glu-val, beta chainSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59538Hb 121(GH4), Glu-val, beta chainDesignated preferred name (PT) NO
RxCUI: 59538Hb 121(GH4), Glu-val, beta chainFull form of descriptor (FN) NO
RxCUI: 595382Anaplasma phagocytophilum antibodyDesignated preferred name (PT) NO
RxCUI: 595382Anaplasma phagocytophilum antibodyFull form of descriptor (FN) NO
RxCUI: 5956IohexolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). YES
RxCUI: 5956IohexolDesignated preferred name (PT) YES
RxCUI: 5956IohexolFull form of descriptor (FN) YES
RxCUI: 5956IohexolDesignated preferred name (PT) YES
RxCUI: 5956IohexolFull form of descriptor (FN) YES
RxCUI: 59561Exo-beta-D-fructosidaseSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59561Exo-beta-D-fructosidaseDesignated preferred name (PT) NO
RxCUI: 59561Exo-beta-D-fructosidaseFull form of descriptor (FN) NO
RxCUI: 59590Hb 125(H8), Leu-proBritish preferred term (PTGB) NO
RxCUI: 59590Hb 125(H8), Leu-proSynonym (SY)Synonym of another TTY, given for clarity. NO
RxCUI: 59590Hb 125(H8), Leu-proDesignated preferred name (PT) NO
RxCUI: 59590Hb 125(H8), Leu-proFull form of descriptor (FN) NO
RxCUI: 595958linolenateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). NO